Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Breast Neoplasms 33Neoplasms 25Prostatic Neoplasms 16Colorectal Neoplasms 13Lung Neoplasms 11Multiple Myeloma 9Head and Neck Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Pancreatic Neoplasms 6Neoplasm Metastasis 6Urinary Bladder Neoplasms 5Hematologic Neoplasms 5Gastrointestinal Neoplasms 5Advanced Cancer 5Uterine Cervical Neoplasms 4Smoking Cessation 4Ovarian Neoplasms 4Melanoma 4Leukemia 4Colonic Neoplasms 4Anxiety Disorders 4Triple Negative Breast Neoplasms 3Stomach Neoplasms 3Small Cell Lung Carcinoma 3Recurrence 3Rectal Neoplasms 3Neoplasms, Plasma Cell 3Motor Activity 3Lymphoma, Follicular 3Lymphedema 3

Interventions

ferrous sulfate 1ferric gluconate 1Standard of Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Iron Deficiencies × Standard of Care × Clear all
NCT00224068 2012-03-02

Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy

Watson Pharmaceuticals

Phase 4 Completed
180 enrolled
Classical hematology

Iron Deficiencies, Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡